Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • SciSure Reviews & Ratings
    4.2 out of 5 stars 311 Ratings
    Company Website for SciSure
  • StackAI Reviews & Ratings
    4.5 out of 5 stars 55 Ratings
    Company Website for StackAI
  • Healthee Reviews & Ratings
    4.6 out of 5 stars 13 Ratings
    Company Website for Healthee
  • Eurekos Reviews & Ratings
    4.8 out of 5 stars 103 Ratings
    Company Website for Eurekos
  • Nalpeiron Zentitle Reviews & Ratings
    4.8 out of 5 stars 31 Ratings
    Company Website for Nalpeiron Zentitle
  • AthenaHQ Reviews & Ratings
    4.9 out of 5 stars 50 Ratings
    Company Website for AthenaHQ
  • FrameworkLTC Reviews & Ratings
    4.4 out of 5 stars 48 Ratings
    Company Website for FrameworkLTC
  • JDisc Discovery Reviews & Ratings
    4.8 out of 5 stars 30 Ratings
    Company Website for JDisc Discovery
  • Criminal IP ASM Reviews & Ratings
    4.9 out of 5 stars 21 Ratings
    Company Website for Criminal IP ASM
  • Gushwork Reviews & Ratings
    4.5 out of 5 stars 29 Ratings
    Company Website for Gushwork

What is Recursion?

Recursion is a pioneering TechBio company reimagining drug discovery through the integration of biology, artificial intelligence, and large-scale data. Founded more than ten years ago, Recursion introduced a novel approach that uses cellular imaging to train AI models to understand disease mechanisms. The company’s mission is to reduce the high failure rate of traditional drug development by uncovering deeper biological insights. At the core of its work is the Recursion OS, a drug discovery and development platform that unifies data, machine learning, and automated experimentation. Recursion has built one of the world’s largest proprietary biological and chemical datasets, spanning phenomics, transcriptomics, proteomics, and patient data. Its automated wet labs generate millions of experiments weekly, creating a continuous feedback loop that improves model performance. This system enables rapid identification of new drug targets and optimized molecule design. Recursion’s pipeline includes multiple programs addressing aggressive cancers and rare diseases with significant unmet needs. The company partners with pharmaceutical leaders, computational technology providers, and data innovators to extend its impact. With BioHive-2, a powerful supercomputer built with NVIDIA, Recursion processes massive datasets at unprecedented speed. These capabilities allow the company to move candidates faster from discovery to clinical trials. Overall, Recursion is focused on delivering better medicines to patients through AI-driven precision and scale.

What is Genomenon?

Pharmaceutical firms need a wealth of genomic information to successfully execute precision medicine strategies; however, they often utilize only a fraction—around 10%—of the total data at their disposal for decision-making. Genomenon offers an extensive database to counter this limitation. Their Prodigy™ Patient Landscapes deliver a cost-effective and efficient approach for conducting natural history research, which is crucial for developing treatments for rare conditions by expanding the understanding of both past and future health data. Employing a sophisticated AI-driven process, Genomenon meticulously analyzes each patient referenced in the medical literature much faster than traditional methods. It is essential to capture all pertinent insights by examining every genomic biomarker highlighted in scholarly articles. Each scientific assertion is backed by solid evidence sourced from medical literature, enabling researchers to identify all genetic factors and pinpoint variants classified as pathogenic according to ACMG clinical criteria, thus streamlining the creation of targeted therapies. By adopting this thorough strategy, pharmaceutical companies can significantly boost their research efficiency and, in turn, enhance patient outcomes. This innovative model not only fosters advancements in drug development but also contributes to a deeper understanding of genetic influences on health.

Media

Media

Integrations Supported

Integrations Supported

Google Cloud Platform

API Availability

API Availability

Has API

Pricing Information

Pricing not provided

Pricing Information

Pricing not provided

Supported Platforms

SaaS

Supported Platforms

SaaS

Customer Service / Support

Standard Support
Web-Based Support

Customer Service / Support

Standard Support
Web-Based Support

Training Options

Documentation Hub
On-Site Training

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Company Facts

Organization Name

Recursion

Company Location

United States

Company Website

www.recursion.com

Company Facts

Organization Name

Genomenon

Company Location

United States

Company Website

www.genomenon.com/pharma/

Categories and Features

AI Science

Not specified

Drug Discovery

Not specified

Healthcare AI

Not specified

Categories and Features

Drug Discovery

Not specified

Healthcare AI

Not specified

Popular Alternatives

Popular Alternatives

VSClinical Reviews & Ratings

VSClinical

Golden Helix